- Exchange: New York
- Sector: -
- Industry: -
- Sub-Industry: Medical-Drugs
More on OPK
News for OPKO HEALTH INC (OPK)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Billionaire Frost Props Up Prolor Bid With Stock Buys
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Billionaire Frost’s Opko to Buy Prolor in $480 Million Deal
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Billionaire Doctor Prescribes Small Teva Deals for Israeli Giant
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Largest NYSE Short Interest Changes as of Nov. 30
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules) Published May 23, 2013
- RXi Pharmaceuticals Reports Financial Results for the First Quarter of 2013 Published May 15, 2013
- OPKO Announces First Quarter 2013 Operating and Financial Highlights Published May 09, 2013
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of PROLOR Published May 02, 2013
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Published Apr 29, 2013
- Lifshitz Law Firm Announces Investigation of Buckeye Technologies Inc., Intuitive Surgical, Inc., MPG Office Trust, Inc., and Published Apr 28, 2013
- Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc. Published Apr 27, 2013
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Published Apr 26, 2013
- PROLOR Biotech, Inc. Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Acquisition Agreement Published Apr 26, 2013
- Law Firm Brower Piven Announces Investigation of PROLOR Biotech, Inc. Proposed Buyout Published Apr 26, 2013
- Rigrodsky & Long, P.A. Announces Investigation Of PROLOR Biotech, Inc. Buyout Published Apr 26, 2013
- Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc. Published Apr 25, 2013
- Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of PROLOR Biotech, Inc. Shareholders Published Apr 25, 2013
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Published Apr 25, 2013
- Ryan & Maniskas, LLP Announces Investigation of PROLOR Biotech, Inc. Published Apr 25, 2013
- European Stocks Fall for Second Day Amid Stimulus Debate Updated 26 minutes ago
- Swiss Stocks Rebound From Their Biggest Drop in 20 Months Updated 59 minutes ago
- Wockhardt Drug Filings Seen Delayed After U.S. FDA Alert Updated 1 hour ago
- U.K. Stocks Drop for Second Day as Investors Consider Fed Updated 2 hours ago
- Apple’s Tax Magic Leaves Irish Bondholders Unmoved: Euro Credit Updated 3 hours ago
- Bonds Rigged as Stocks Expensive for Money Man Doubling Fund
- Elan Board Unanimously Rejects $6.4B Takeover Offer
- Wockhardt Has Biggest 2-Day Drop on Record on U.S. Restrictions
- IPhone Urinalysis Draws First FDA Inquiry of Medical Apps
- Five Key Things About the SAC Insider Case
- Merck Insomnia Drug Safe Only in Low Doses
- Merck Halts Development of Parkinson’s Drug on Lack of Benefit
- Emerging Stocks Cap Biggest Decline in 10 Months on China
- J&J Drugs to Create Next Wave of Growth, Duato Says
- Merck Insomnia Drug Safe Only in Lower Doses, Panel Says
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page